These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9116484

  • 1. Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
    Bowers MB.
    J Neuropsychiatry Clin Neurosci; 1996; 8(4):450-2. PubMed ID: 9116484
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of patients with the highest plasma catecholamine metabolite levels.
    Bowers MB, Swigar ME, Hoffman FJ, Goicoechea N.
    Am J Psychiatry; 1988 Feb; 145(2):246-8. PubMed ID: 3422545
    [Abstract] [Full Text] [Related]

  • 3. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395
    [Abstract] [Full Text] [Related]

  • 4. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis.
    Devanand DP, Bowers MB, Hoffman FJ, Nelson JC.
    Psychiatry Res; 1985 May 01; 15(1):1-4. PubMed ID: 3859880
    [Abstract] [Full Text] [Related]

  • 5. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.
    Encephale; 1992 May 01; 18(6):611-6. PubMed ID: 1285270
    [Abstract] [Full Text] [Related]

  • 6. Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
    Bowers MB.
    Biol Psychiatry; 1993 Oct 15; 34(8):584-6. PubMed ID: 8274591
    [No Abstract] [Full Text] [Related]

  • 7. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D.
    Arch Gen Psychiatry; 1987 Sep 15; 44(9):782-9. PubMed ID: 3632251
    [Abstract] [Full Text] [Related]

  • 8. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions.
    Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA.
    Arch Gen Psychiatry; 1988 Feb 15; 45(2):162-6. PubMed ID: 3337614
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease.
    Lloyd KG.
    Prim Care; 1977 Sep 15; 4(3):561-75. PubMed ID: 264230
    [Abstract] [Full Text] [Related]

  • 10. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman F, Giocoechea N.
    Compr Psychiatry; 1986 Sep 15; 27(3):181-5. PubMed ID: 2872015
    [No Abstract] [Full Text] [Related]

  • 11. Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
    Harvey NS.
    Psychosomatics; 1986 Feb 15; 27(2):91-3, 97-8, 102-3. PubMed ID: 3513232
    [No Abstract] [Full Text] [Related]

  • 12. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP, Bowers MB, Hoffman FJ, Sackeim HA.
    Biol Psychiatry; 1989 Aug 15; 26(4):408-12. PubMed ID: 2765601
    [No Abstract] [Full Text] [Related]

  • 13. Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
    Umene-Nakano W, Yoshimura R, Yoshii C, Hayashi K, Ikenouchi-Sugita A, Katsuki A, Hori H, Nakamura J.
    Nicotine Tob Res; 2012 Apr 15; 14(4):486-9. PubMed ID: 22006914
    [Abstract] [Full Text] [Related]

  • 14. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB, Mazure CM, Nelson JC, Jatlow PI.
    Biol Psychiatry; 1992 Dec 15; 32(12):1102-7. PubMed ID: 1477190
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
    Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S.
    Schizophr Bull; 1995 Dec 15; 21(1):53-66. PubMed ID: 7770741
    [Abstract] [Full Text] [Related]

  • 16. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ.
    Biol Psychiatry; 1989 Mar 15; 25(6):734-8. PubMed ID: 2923935
    [Abstract] [Full Text] [Related]

  • 17. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 15; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma monoamine metabolites in eating disorders.
    Bowers MB, Mazure CM, Greenfeld DG.
    Psychiatry Res; 1994 Apr 15; 52(1):11-5. PubMed ID: 8047617
    [Abstract] [Full Text] [Related]

  • 19. Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease.
    Olanow CW, Gauger LL, Cedarbaum JM.
    Ann Neurol; 1991 May 15; 29(5):556-9. PubMed ID: 1859185
    [Abstract] [Full Text] [Related]

  • 20. Reproducibility of plasma catecholamine metabolites in normal subjects.
    Amin F, Hashmi A, Stroe AE, Adebogun O, Densmore D, Knott PJ.
    Biol Psychiatry; 1998 Feb 01; 43(3):233-5. PubMed ID: 9494706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.